Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvanted vs Non-adjuvanted Influenza Vaccine in Adults with Chronic Diseases
NCT00519064Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Primary completion
- Dec 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine (surface antigen, inactivated, adjuvanted) in influenza, sponsored by Novartis. Started Nov 2006; status: completed.
02
Drugs
influenza vaccine (surface antigen, inactivated, adjuvanted)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00519064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519064.